glp 1 and inflammation GLP-1 Receptor Agonists Reduce Frontiers | The role of

Ozempic is considered a first-line treatment for Type 2 diabetes only if you have cardiovascular disease (CV disease) or are at high risk for CV disease

Semaglutide at higher doses (2.4 mg weekly) has shown the most robust evidence for NASH resolution in clinical trials, achieving resolution in 59% of patients

Patients using GLP-1 for obesity treatment have reported an average weight loss of 15% or more of their body weight within a year

Talking to Your Provider If youre currently breastfeeding and eager to start GLP-1 treatment, the most important step is having an honest conversation with your prescriber about your timeline

For those on GLP-1 medications, dietary fibre is important for preventing constipation together with adequate hydration